Literature DB >> 29532984

Blood pressure reduced to new guideline goals in patients with high-normal glucose further reduces cardiovascular events.

Omar Al Dhaybi1, George L Bakris1.   

Abstract

Entities:  

Keywords:  fasting blood glucose; hypertension; intensive; standard; therapy

Mesh：

Substances：

Year:  2018        PMID： 29532984      PMCID： PMC8031035          DOI： 10.1111/jch.13242

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN： 1524-6175            Impact factor:   3.738


× No keyword cloud information.
  12 in total

Review 1.  Effects of blood-pressure-lowering treatment on outcome incidence in hypertension: 10 - Should blood pressure management differ in hypertensive patients with and without diabetes mellitus? Overview and meta-analyses of randomized trials.

Authors:  Costas Thomopoulos; Gianfranco Parati; Alberto Zanchetti
Journal:  J Hypertens       Date:  2017-05       Impact factor: 4.844

2.  Effect of intensive blood pressure control in patients with type 2 diabetes mellitus over 9 years of follow-up: A subgroup analysis of high-risk ACCORDION trial participants.

Authors:  Leo F Buckley; Dave L Dixon; George F Wohlford; Dayanjan S Wijesinghe; William L Baker; Benjamin W Van Tassell
Journal:  Diabetes Obes Metab       Date:  2018-03-02       Impact factor: 6.577

Review 3.  The impact of sleep amount and sleep quality on glycemic control in type 2 diabetes: A systematic review and meta-analysis.

Authors:  Shaun Wen Huey Lee; Khuen Yen Ng; Weng Khong Chin
Journal:  Sleep Med Rev       Date:  2016-02-09       Impact factor: 11.609

4.  Day-to-day variability of fasting plasma glucose in newly diagnosed type 2 diabetic subjects.

Authors:  R L Ollerton; R Playle; K Ahmed; F D Dunstan; S D Luzio; D R Owens
Journal:  Diabetes Care       Date:  1999-03       Impact factor: 19.112

5.  Effects of intensive blood-pressure control in type 2 diabetes mellitus.

Authors:  William C Cushman; Gregory W Evans; Robert P Byington; David C Goff; Richard H Grimm; Jeffrey A Cutler; Denise G Simons-Morton; Jan N Basile; Marshall A Corson; Jeffrey L Probstfield; Lois Katz; Kevin A Peterson; William T Friedewald; John B Buse; J Thomas Bigger; Hertzel C Gerstein; Faramarz Ismail-Beigi
Journal:  N Engl J Med       Date:  2010-03-14       Impact factor: 91.245

6.  Impaired fasting glucose, blood pressure and cardiovascular disease mortality.

Authors:  Patrick Henry; Frédérique Thomas; Athanase Benetos; Louis Guize
Journal:  Hypertension       Date:  2002-10       Impact factor: 10.190

7.  Blood pressure reduced to new guideline goals in patients with high-normal glucose further reduces cardiovascular events.

Authors:  Omar Al Dhaybi; George L Bakris
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-03-13       Impact factor: 3.738

8.  Intensive blood pressure lowering reduces adverse cardiovascular outcomes among patients with high-normal glucose: An analysis from the Systolic Blood Pressure Intervention Trial database.

Authors:  Yan Gong; Steven M Smith; Eileen M Handberg; Carl J Pepine; Rhonda M Cooper-DeHoff
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-03-13       Impact factor: 3.738

Review 9.  2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Authors:  Paul K Whelton; Robert M Carey; Wilbert S Aronow; Donald E Casey; Karen J Collins; Cheryl Dennison Himmelfarb; Sondra M DePalma; Samuel Gidding; Kenneth A Jamerson; Daniel W Jones; Eric J MacLaughlin; Paul Muntner; Bruce Ovbiagele; Sidney C Smith; Crystal C Spencer; Randall S Stafford; Sandra J Taler; Randal J Thomas; Kim A Williams; Jeff D Williamson; Jackson T Wright
Journal:  Hypertension       Date:  2017-11-13       Impact factor: 9.897

10.  Outcomes of combined cardiovascular risk factor management strategies in type 2 diabetes: the ACCORD randomized trial.

Authors:  Karen L Margolis; Patrick J O'Connor; Timothy M Morgan; John B Buse; Robert M Cohen; William C Cushman; Jeffrey A Cutler; Gregory W Evans; Hertzel C Gerstein; Richard H Grimm; Edward W Lipkin; K M Venkat Narayan; Matthew C Riddle; Ajay Sood; David C Goff
Journal:  Diabetes Care       Date:  2014-03-04       Impact factor: 19.112
View more
  1 in total

1.  Blood pressure reduced to new guideline goals in patients with high-normal glucose further reduces cardiovascular events.

Authors:  Omar Al Dhaybi; George L Bakris
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-03-13       Impact factor: 3.738
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.